Effects of gastrointestinal prokinetic agents, TKS159 and cisapride, on the in situ canine heart assessed by cardiohemodynamic and electrophysiological monitoring

Toxicology and Applied Pharmacology

Volumn 152, Issue 1, 1998, Pages 261-269

  Sugiyama, Atsushi ^a   Hashimoto, Keitaro ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

5 HT4; Cisapride; Long QT syndrome; Monophasic action potential; TKS159

Indexed keywords

4 AMINO 5 CHLORO 2 METHOXY N 1 ETHYL 2 HYDROXYMETHYL 4 PYRROLIDINYL]BENZAMIDE; 4 AMINO 5 CHLORO N (1 ETHYL 2 HYDROXYMETHYL 4 PYRROLIDINYL) 2 METHOXYBENZAMIDE; CISAPRIDE; PROKINETIC AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATRIOVENTRICULAR CONDUCTION; BLOOD PRESSURE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG SAFETY; HEART ELECTROPHYSIOLOGY; HEART HEMODYNAMICS; HEART MUSCLE REFRACTORY PERIOD; HEART OUTPUT; HEART RATE; HEART REPOLARIZATION; MEAN ARTERIAL PRESSURE; NONHUMAN;

EID: 0031737379     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1998.8494     Document Type: Article

References (29)

1. Ahmad, S. R., and Wolfe, S. M. (1995). Cisapride and torsades de pointes. Lancet 345, 508.
2. Bazett, H. C. (1918). An analysis of the time relations of electrocardiogram. Heart 7, 353-370.
3. Bran, S., Murray, W. A., Hirsch, I. B., and Palmer, J. P. (1995). Long QT syndrome during high-dose cisapride. Arch. Intern. Med. 155, 765-768.
4. Carlsson, L., Amos, G. J., Andersson, B., Drews, L., Duker, G., and Wadstedt, G. (1997). Electrophysiological characterization of the prokinetic agents cisapride and mosapride in vivo and in vitro: Implications for proarrhythmic potential? J. Pharmacol. Exp. Ther. 282, 220-227.
5. Franz, M. R. (1994). Bridging the gap between basic and clinical electrophysiology: What can be learned from monophasic action potential recordings? J. Cardiovasc. Electrophysiol. 5, 699-710.
6. Franz, M. R., and Costard, A. (1988). Frequency-dependent effects of quinidine on the relationship between action potential duration and refractoriness in the canine heart in situ. Circulation 77, 1177-1184.
7. Hanson, R., Browne, G., Fasher, B., and Mcaskill, M. (1997). Cisapride-induced prolonged QT interval: Too much of a good things! J. Pediatr. 130, 164-166.
8. Hashimoto, K., Haruno, A., Matsuzaki, T., Sugiyama, A., and Akiyama, K. (1991). Effects of antiarrhythmic drugs on canine ventricular arrhythmia model: Which electrophysiological characteristics of drugs are related to their effectiveness? Cardiovasc. Drugs Ther. 5, 805-818.
9. Hey, J. A., del Prado, M., Sherwood, J., Kreutner, W., and Egan, R. W. (1996). Comparative analysis of the cardiotoxicity proclivities of second generation antihistamines in an experimental model predictive of adverse clinical ECG effects. Arzneim-Forsch/Drug Res. 46, 153-158.
10. Hondeghem, L. M., and Snyders, D. J. (1990). Class III antiarrhythmic agents have a lot of potential but a long way to go: Reduced effectiveness and dangers of reverse use dependence. Circulation 81, 686-690.
11. 4 receptors mediate arrhythmias? Trends Pharmacol. Sci. 15, 451-455.
12. 4-like receptor in human right atrium. Naunyn-Schmied. Arch. Pharmacol. 344, 150-159.
13. 4-like receptors. Naunyn-Schmied. Arch. Pharmacol. 342, 619-622.
14. 4-receptor agonists, cisapride, mosapride citrate, and zacopride, on cardiac action potentials in guinea pig isolated papillary muscles. J. Cardiovasc. Pharmacol. 29, 670-675.
15. Lewin, M. B., Bryant, R. M., Fenrich, A. L., and Grifka, R. G. (1996). Cisapride-induced long QT interval. J. Pediatr. 128, 279-281.
16. 4) receptors in guinea pig stomach: The effect of TKS159, a novel agonist, on gastric motility and acetylcholine release. J. Pharmacol. Exp. Ther. 276, 989-995.
17. 4 receptor mediating tachycardia in piglet isolated right atrium. Br. J. Pharmacol. 110, 1023-1030.
18. Morgan Jr, T. K., and Sullivan, M. E. (1992). An overview of class III electrophysiological agents: a new generation of antiarrhythmic therapy. In Progress in Medicinal Chemistry (G. P. Ellis and D. K. Luscombe, Eds.), pp. 65-108. Elsevier Science Publishers B. V, Amsterdam.
19. Nattel, S., and Zeng, F. D. (1984). Frequency-dependent effects of antiarrhythmic drugs on action potential duration and refractoriness of canine cardiac Purkinje fibres. J. Pharmacol. Exp. Ther. 229, 283-291.
20. Olsson, S., and Edwards, I. R. (1992). Tachycardia during cisapride treatment. Br. Med. J. 305, 748-749.
21. Puisieux, F. L., Adamantidis, M. M., Dumotier, B. M., and Dupuis, B. A. (1996). Cisapride-induced prolongation of cardiac action potential and early afterdepolarizations in rabbit Purkinje fibres. Br. J. Pharmacol. 117, 1377-1379.
22. Sugiyama, A., Aye, N. N., Katahira, S., Saitoh, M., Hagihara, A., Matsubara, Y., and Hashimoto, K. (1997a). Effects of nonsedating antihistamine, astemizole, on the in situ canine heart assessed by cardiohemodynamic and monophasic action potential monitoring. Toxicol. Appl. Pharmacol. 143, 89-95.
23. Sugiyama, A., Aye, N. N., Katahira, S., Hagihara, A., and Hashimoto, K. (1997b). Effects of magnesium sulfate on the canine cardiovascular system complicating astemizole overdose. J. Cardiovasc. Pharmacol. 29, 795-800.
24. Sugiyama, A., Ni, C., Arita, J., Eto, K., Xue, Y. X., and Hashimoto, K. (1996). Effects of the antihypoxic and neuroprotective drug, lubeluzole, on repolarization phase of canine heart assessed by monophasic action potential recording. Toxicol. Appl. Pharmacol. 139, 109-114.
25. Sugiyama, A., Motomura, S., and Hashimoto, K. (1994). Utilization of an isolated, blood-perfused canine papillary muscle preparation as a model to assess efficacy and adversity of class I antiarrhythmic drugs. Jpn. J. Pharmacol. 66, 303-316.
26. 4 receptor mediating tachycardia in the pig. Br. J. Pharmacol. 102, 107-112.
27. Wiseman, L. R., and Faulds, D. (1994). Cisapride: An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders. Drugs 47, 116-152.
28. Wysowski, D. K., and Bacsanyi, J. (1996). Cisapride and fatal arrhythmia. N. Engl. J. Med. 335, 290-291.
29. Zipes, D. P. (1991). Monophasic action potentials in the diagnosis of triggered arrhythmias. Prog. Cardiovasc. Dis. 33, 385-396.